QA: REGENERX BIOPHARMACEUTICALS INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000707511_2018_REGENERX_BIOPHARMACEUTICALS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000707511')"}

Graph

Absolute values for 0000707511, REGENERX BIOPHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 217,150
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,171
3 remainder_Assets 5,752
4 LiabilitiesCurrent 2,153,089
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,190,276
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,357,371
9 ResearchAndDevelopmentExpense 143,911
10 remainder_Expenses 98,605
11 remainder_Revenues 56,652
12 remainder_NetIncome 1,829,722
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 227,073
1 Liabilities 4,343,365
2 Expenses 1,599,887
3 Revenues 56,652
4 StockholdersEquity -4,116,292
5 NetIncome 286,487
6 ComprehensiveNetIncome 286,487
7 BaseVar 4,028,350
8 EconomicCapitalRatio -2.97

Edgar->Model Mapping

Feature Distribution

Change over Time